Refresh

Mangalam Drugs and Organics Ltd. - Research Center

532637 MANGALAM Group (B) BSE data
Back to Company

Results

Statement

More

Profit & Loss Account
(Rs crore)
Mar ' 23 Mar ' 22 Mar ' 21 Mar ' 20 Mar ' 19
Income

Operating income

372.25 451.07 380.14 282.35 227.58
Expenses

Material consumed

255.12 311.20 255.84 198.43 155.23

Manufacturing expenses

25.59 22.90 16.12 14.24 14.56

Personnel expenses

34.61 37.25 29.88 26.04 25.82

Selling expenses

1.36 2.44 0.61 0.96 0.76

Adminstrative expenses

30.06 28.22 24.39 18.98 21.54

Expenses capitalised

- - - - -

Cost of sales

346.73 402.01 326.84 258.66 217.90

Operating profit

25.52 49.05 53.30 23.69 9.68

Other recurring income

0.44 0.09 4.72 1.18 0.32

Adjusted PBDIT

25.95 49.14 58.02 24.87 10.00

Financial expenses

12.75 11.16 9.33 10.40 8.65

Depreciation

10.99 10.25 9.18 8.22 7.09

Other write offs

- - - - -

Adjusted PBT

2.21 27.73 39.52 6.25 -5.74

Tax charges

0.94 8.08 11.55 -2.00 2.29

Adjusted PAT

1.27 19.66 27.97 8.25 -8.03

Non recurring items

- - - - -0.08

Other non cash adjustments

- - - - -

Reported net profit

1.27 19.66 27.97 8.25 -8.11

Earnigs before appropriation

103.26 101.99 82.51 54.54 46.29

Equity dividend

- - - - -

Preference dividend

- - - - -

Dividend tax

- - - - -

Retained earnings

103.26 101.99 82.51 54.54 46.29
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com